ZANTE GREG (Chief Financial Officer) sold 27.6% of their position (66.76K shares) of VIKING THERAPEUTICS, INC. on the open market

Open‑market sale worth $4.99M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 4 sales

ZANTE GREG

Filed: 5/3/2024ACC: 0001209191-24-005522

InsiderZANTE GREGCIK 1264949

→

IssuerVIKING THERAPEUTICS, INC.CIK 1607678

Officer· Chief Financial Officer

Since Jan 2021

-66.76K

Net shares

Net seller

$4.99M

Total sold

Open market trades

0B · 4S

Total transactions

34.25K acquired · 101K disposed

Non-Derivative Transactions6

Common Stock, par value $0.00001 per share

Direct

M · Option Exercise

+4.25K

Price / share

$4.68

Trade value

$19.89K

% of position

2.0%

5/3/2024

207.36K→211.61K

Common Stock, par value $0.00001 per share

Direct

M · Option Exercise

+30K

Price / share

$4.88

Trade value

$146.40K

% of position

14.2%

5/3/2024

211.61K→241.61K

Common Stock, par value $0.00001 per share

Direct

S · Sale

−3.10K

Price / share

$73.49

Trade value

$227.89K

% of position

1.3%

5/3/2024

241.61K→238.51K

Common Stock, par value $0.00001 per share

Direct

S · Sale

−45.57K

Price / share

$74.44

Trade value

$3.39M

% of position

19.1%

5/3/2024

238.51K→192.94K

Common Stock, par value $0.00001 per share

Direct

S · Sale

−17.24K

Price / share

$75.49

Trade value

$1.30M

% of position

8.9%

5/3/2024

192.94K→175.70K

Common Stock, par value $0.00001 per share

Direct

S · Sale

−847.00

Price / share

$76.07

Trade value

$64.43K

% of position

0.5%

5/3/2024

175.70K→174.85K

Total

Net shares

−32.51K

Net value

-$4.82M

Security	Date	Type	Shares	Price / Share	Trade Value	% of Position	Held Before	Held After
Common Stock, par value $0.00001 per share Direct	5/3/2024	M · Option Exercise	+4.25K	$4.68	$19.89K	2.0%	207.36K	211.61K
Common Stock, par value $0.00001 per share Direct	5/3/2024	M · Option Exercise	+30K	$4.88	$146.40K	14.2%	211.61K	241.61K
Common Stock, par value $0.00001 per share Direct	5/3/2024	S · Sale	−3.10K	$73.49	$227.89K	1.3%	241.61K	238.51K
Common Stock, par value $0.00001 per share Direct	5/3/2024	S · Sale	−45.57K	$74.44	$3.39M	19.1%	238.51K	192.94K
Common Stock, par value $0.00001 per share Direct	5/3/2024	S · Sale	−17.24K	$75.49	$1.30M	8.9%	192.94K	175.70K
Common Stock, par value $0.00001 per share Direct	5/3/2024	S · Sale	−847.00	$76.07	$64.43K	0.5%	175.70K	174.85K
Total			−32.51K		-$4.82M

Derivative Transactions2

Stock Option (Right to Buy)

Direct

M · Option Exercise

Converts to

Common Stock

4.25K shares

−4.25K

Strike price

4.68

Held after

4.25K

Exercisable

—

5/3/2024

Stock Option (Right to Buy)

Direct

M · Option Exercise

Converts to

Common Stock

30K shares

−30K

Strike price

4.88

Held after

60K

Exercisable

—

5/3/2024

Security	Converts To	Date	Type	Shares	Strike Price	Exercisable	Held After
Stock Option (Right to Buy) Direct	Common Stock4.25K shares	5/3/2024	M · Option Exercise	−4.25K	4.68	—	4.25K
Stock Option (Right to Buy) Direct	Common Stock30K shares	5/3/2024	M · Option Exercise	−30K	4.88	—	60K